Comment

‘The World Needs A Cannabis Initiative That Serves Citizens. Not One That Serves A Decadent International Bureaucracy’

By European cannabis researcher and thought-leader Kenzi Riboulet-Zemouli THERE is much concern over the International Narcotics Control Board’s Cannabis Control Initiative, as reported by BusinessCann earlier...

Tokyo 2020: How Cannabis Has Changed The Games

By Barbara Pastori IT'S been a long road, but the Olympic torch finally landed in Japan on July 23. The latest edition of the Games...

The Cannabis Industry Council – ‘The Reasonable, Constructive And Pro-Active Face Of UK Cannabis’

THE newly launched Cannabis Industry Council has brought together disparate organisations, working groups and businesses with the aim of driving meaningful change within the...

Learning From Canada’s Mistakes; Why Firms Should Double Down On Medical Cannabis In Europe

By: Max Monahan-Ellison  AS hype and excitement builds around the potential for recreational cannabis legalization in some European countries, it’s an opportune time to share...

Why The Delay? A Leading Novel Food Expert Examines The FSA’s CBD Dilemma

"OVER the past couple of weeks there have been no updates to the Food Standards Agency’s (FSA) public registers for CBD novel food applications....

Courage and Cannabidiol: Novel Food CBD Will Crush Small British Business

By Peter Reynolds, of CannaPro THIS is the story of how brave British small-businesses created a £1.7bn market and now face destruction at the hands...

Five Key Pointers For US Firms Looking To Enter the European CBD Market

Stuart McKenzie, Founder and CEO of Reakiro, offers some guidance for North American firms looking to Europe's CBD markets WHILE the CBD boom...

Novel Food Opens Up ‘A Wealth Of Opportunities For The CBD Industry’ Says The ACI

Dr Paul Duffy, Toxicology Associate, at the ACI, elaborates on its Novel Food applications and the significance of these development for the the CBD industry THIS...

‘The Dutch Bedrocan Medicine Is The Only Viable Option For Treating Many Children’s Epilepsy’

Prof Mike Barnes, one of the UK's leading cannabis clinicians responds to suggestions that the medicines for UK children with epilepsy can be sourced...

‘Failing’ Government Report Into Medicinal Cannabis Is A ‘Missed Opportunity’

The Advisory Council for the Misuse of Drugs' recent report on cannabis medicines is a missed opportunity, says Pierre Van Weperen of The Grow...

Under the Biden-Harris Presidency The Cannabis Industry Can Deliver A Significant Boost To The Whole US Economy

Ex-pat Brit cannabis entrepreneur Elle Rahman, CEO of Oregon-based OME Health, elaborates on what the recent Election means for the industry in the USA. UNDER a...

CBD A Narcotic? Expect A Legal Challenge If EC Proceeds With This Classification – UK Lawyer Robert Jappie

Leading cannabis Lawyer Robert Jappie of law firm Ince reflects on the shifting status of CBD in Europe THE European Commission has paused consideration of...

It’s Time To ‘Open Cannabis’ Prescriptions To NHS Patients

Alex Fraser, Patient Access Lead with Grow Pharma, on the recently-launched 'Open Cannabis' campaign THE truth is there are a huge number of patients...

Austrian CBD Firms And Regulators Work To Create Safe And Compliant Industry

AUSTRIAN seed-to-sale CBD firm MAGU says the future looks brighter under a new cannabis-friendly Government. Co-Founder Sofie Sagmeister elaborates. “COVID-19 has hit us hard -...

The Potential Impacts Of The Controversial KanaVape Case Examined By Tim Phillips Of CBD-Intel

AS the KanaVape case awaits European Court of Justice (ECJ) ratification its implications for the hemp and CBD markets across the continent...

Bruce Linton: ‘I’ve Secured More Investment Capital Than Greece’

BEFORE heading off to Greece to persuade its politicians to commit to the cannabis industry, former Canopy Growth Chief Executive Bruce Linton elaborated on...

Latest news

MGC Pharmaceuticals Releases Update On CimetrA Clinical Trial Progress In USA

MGC Pharmaceuticals Ltd (ASX, LSE: MXC, ‘MGC Pharma’ or ‘the Company’), a European based bio-pharma company specialising in the production and development...

European Cannabis Stocks Review: Akanda’s ‘Concerned Shareholders’ Oust All Directors Except CEO To Prevent ‘Potentially Irreparable Harm’ – More From Goodbody Health & Chill...

It has been another week of positive developments for the cannabis industry across Europe, with yet more markets making...

Analysis Shows UK Market Could Grow To Over £1bn By 2026 As London Prepares To Host Europe’s Leading Cannabis Conference

ANALYSIS shows UK market could grow to over £1bn by 2026 as London prepares to host Europe’s leading cannabis...

Must read

You might also likeRELATED
Recommended to you

Fall in Number Of UK Cannabis Users

ONE of the UK’s leading cannabis experts says the...

Fall in Number Of UK Cannabis Users

ONE of the UK’s leading cannabis experts says the...

Fall in Number Of UK Cannabis Users

ONE of the UK’s leading cannabis experts says the...